Background-The evolution of cell phenotypes and matrix architecture in cardiac valves during fetal maturation and postnatal adaptation through senescence remains unexplored. Methods and Results-We hypothesized that valvular interstitial (VIC) and endothelial cell (VEC) phenotypes, critical for maintaining valve function, change throughout life in response to environmental stimuli. We performed quantitative histological assessment of 91 human semilunar valves obtained from fetuses at 14 to 19 and 20 to 39 weeks' gestation; neonates minutes to 30 days old; children aged 2 to 16 years; and adults. A trilaminar architecture appeared by 36 weeks of gestation but remained rudimentary compared with that of adult valves. VECs expressed an activated phenotype throughout fetal development. VIC density, proliferation, and apoptosis were significantly higher in fetal than adult valves. Pulmonary and aortic fetal VICs showed an activated myofibroblast-like phenotype (␣-actin expression), abundant embryonic myosin, and matrix metalloproteinase-collagenases, which indicates an immature/activated phenotype engaged in matrix remodeling versus a quiescent fibroblast-like phenotype in adults. At birth, the abrupt change from fetal to neonatal circulation was associated with a greater number of ␣-actin-positive VICs in neonatal aortic versus pulmonary valves. Collagen content increased from early to late fetal stages but was subsequently unchanged, whereas elastin significantly increased postnatally. Collagen fiber color analysis revealed a progressive temporal decrease in thin fibers and a corresponding increase in thick fibers. Additionally, collagen fibers were more aligned in adult than fetal valves. 
A n understanding of extracellular matrix (ECM) architecture and cellular changes that occur in cardiac valves during fetal development, maturation, and aging would provide mechanistic insights into the pathogenesis of congenital and acquired valve abnormalities, aid assessment of therapeutic strategies for valve disease, and assist in the development of regenerative and tissue-engineered approaches to valve repair and replacement. Although the mechanisms of valvulogenesis in early cardiac development have been elucidated, [1] [2] [3] [4] [5] subsequent cellular and ECM maturation, remodeling, and growth processes, particularly in humans, remain unexplored.
ECM in general and collagen in particular play a crucial role in valve function and durability. Indeed, valves must accommodate substantial changes in hemodynamic environment and structure throughout a lifetime. Furthermore, valvular interstitial (VIC) and endothelial cell (VEC) functions likely influence ECM synthesis and remodeling. For example, activated myofibroblast-like VICs are critical to collagen metabolism and are altered in some valve diseases, including myxomatous degeneration of the mitral valve. 6 We recently showed that large populations of VICs undergo phenotypic modulation to become activated myofibroblasts and return to quiescent fibroblasts during adaptive remodeling in response to changing environmental conditions, which we have observed in long-term pulmonary autografts and in tissueengineered valves. [7] [8] [9] We therefore tested the hypothesis that phenotypic changes in valvular cells, determined by altered expression of cytoskeletal and surface proteins and by proteolytic enzymes, regulate age-associated structural remodeling and adaptation of the ECM. Specifically, we characterized phenotypes and turnover of VIC and VEC in human fetal, neonatal, child, and adult semilunar valves and correlated cellular changes with alterations in valvular ECM.
Methods

Morphological Characterization
We studied 91 human semilunar valves: fetal valves in the second trimester (14 to 19 weeks' gestation; nϭ11) and third trimester (20 to 39 weeks' gestation; aortic nϭ10, pulmonary nϭ10); neonatal (early neonatal with minutes to hours of survival: aortic nϭ5, pulmonary nϭ5; late neonatal [up to 30 days of survival]: aortic nϭ5, pulmonary nϭ5); valves from children (aged 6.0Ϯ1.6 years; aortic nϭ10, pulmonary nϭ10); and valves from normal adults (aged 50.1Ϯ2.5 years; aortic nϭ10, pulmonary nϭ10) obtained at autopsy according to a protocol for tissue use approved by the Human Research Committee at Brigham and Women's Hospital. No patient had documented cardiac disease or conditions known to predispose to heart valve disease. Examination revealed no evidence of valve disease, and the fetal heart morphology appeared appropriate for the gestational age.
Valves were fixed in 10% buffered formalin, cut radially in the central cusp region through the adjacent arterial wall, and embedded in paraffin. Sections cut at 6-m thickness were stained with hematoxylin and eosin for general morphological assessment. We used Movat pentachrome stain to differentiate connective tissue elements (collagen, elastin, and proteoglycans) and picrosirius red viewed with circularly polarized light to assess collagen architecture. 6,10 All 3 cusps from each aortic and pulmonary valve were analyzed.
Characterization of Cell Phenotype and Turnover
Markers of cell phenotype and synthetic products were identified by immunohistochemistry. We defined myofibroblasts like VICs as cells that had antibody reaction to ␣-smooth muscle actin (␣-SMA, 1A4, Dako, Carpenteria, Calif). 6, 11 Mouse monoclonal antibodies against human metalloproteinase-1 (MMP-1/collagenase-1) and MMP-13/collagenase-3 (Calbiochem, San Diego, Calif) were used to determine proteolytic enzyme expression. Cell activation was also demonstrated by a monoclonal antibody against human SMemb 12 (a nonmuscle myosin also known as MHC-B, expressed by embryonic or activated mesenchymal cells). Phenotypic changes in valvular endothelium were assessed by antibodies to CD31 (Dako), intercellular adhesion molecule-1 (ICAM-1; US Biological, Swampscott, Mass), and vascular cell adhesion molecule-1 (VCAM-1; US Biological). Immunohistochemistry methods used avidin-biotinperoxidase after antigen unmasking pretreatment with proteinase K for 5 minutes at room temperature. Adjacent sections treated with nonimmune IgG provided controls for antibody specificity. Cell proliferation was demonstrated with the Ki-67 (MIB-1, Dako) antigen, which is present during active phases of the cell cycle but absent in resting cells, and cell apoptosis was demonstrated by terminal dUTP nick end-labeling (TUNEL) assay (Intergen, New York, NY). Commercially available human lymph node and thymus sections provided positive controls. Images were captured and analyzed with a digital camera (Nikon DXM1200-F, Nikon Inc, Melville, NY) and imaging software (ACT-1 version 2.63, Nikon).
Cell density was measured as mean number of cells per 10 high-power fields (ϫ400) and expressed as cell number per square millimeter of the tissue section in each cusp. Cell proliferation and apoptosis indices were calculated as the ratio of Ki-67 and TUNELpositive cells, respectively, to the total number of valve cusp cell nuclei. The ratio of ␣-SMA, MMP-1, MMP-13, and SMemb-positive cells to the total cell number was averaged over 5 representative high-power fields. The ratio of ICAM-1-and VCAM-1-positive cells to total CD31-positive cells was calculated for each cusp. Only cells expressing an antigen of interest (defined as red reaction product associated with blue hematoxylin nuclear counterstain) were counted. All measurements were done by 2 independent researchers.
Collagen and Elastin Assessment
We used picrosirius red staining in conjunction with polarized light microscopy to assess collagen fiber content, thickness, and organization and Movat pentachrome to detect elastin (Olympus BX51 microscope, Olympus America Inc, Melville, NY).
Collagen Content and Fiber Color
With this microscopy combination, collagen fiber color is determined by thickness; the color changes from green to yellow to orange to red as thickness increases. 13 We assessed the proportion of different colored fibers using published methods. 14, 15 Briefly, we recorded images viewed with circularly polarized light 16 using a digital camera (DP11, Olympus) and analyzed 2 regions (260ϫ200 m) per valve. Images were resolved, using an automated software function (SigmaScan Pro; SPSS Inc, Chicago, Ill), into their hue, saturation, and value components. We retained only the hue component, and a histogram of hue frequency was obtained from the 8-bit hue images that contained 256 possible colors, defined as follows; red 2 to 9 and 230 to 256, orange 10 to 38, yellow 39 to 51, and green 52 to 128. 14 All other hue values corresponded to interstitial space, confirmed by inspection. We determined the number of pixels within each hue range and expressed this as a percentage of the total number of collagen pixels, which in turn was expressed as a percentage of the total number of pixels in the regions analyzed to give collagen content.
Collagen Orientation
The optical properties of birefringent materials, such as collagen, can be exploited to determine their 2D orientation. 17 We used a recently developed automated system (PolScope, CRI, Inc, Woburn, Mass) to measure collagen fiber orientation at 100 locations in each valve, with locations selected by construction of a 10ϫ5-point rectangular grid overlying 2 regions in each valve. An orientation frequency distribution was obtained for each region. Briefly, the system uses an electronically controlled liquid crystal compensator to acquire and record images, with a CCD camera, at 4 predetermined compensator settings. Algorithms are used to calculate the orientation angle of the slow optical axis of the birefringent collagen from the data obtained in these images 18 given the property that the slow optical axis of collagen corresponds to the long-axis orientation of the fibers. Each distribution was analyzed with circular statistics, which are methods designed to examine directional data. 19 The degree of fiber alignment was assessed by calculation of the angular deviation of the distribution, the circular statistics' equivalent of standard deviation; the smaller the angular deviation, the more aligned the fibers. 17 
Elastin Content
Movat pentachrome stains elastin black, collagen yellow, and glycosaminoglycans blue-green. Elastin-positive areas were measured in 3 high-power fields of each cusp in the ventricularis layer with imaging software (IPLab version 3.9.3; Scanalytics, Inc, Rockville, Md).
Statistical Analyses
Data are presented as meanϮSEM. Group differences were evaluated with ANOVA followed by pairwise comparisons with the Tukey-Kramer post hoc test; however, t tests were used when 2 groups were compared. Probability values less than 0.05 were considered significant.
The authors had full access to the data and take full responsibility for its integrity. All authors have read and agree to the manuscript as written.
Results
Fetal Valves Have an Incomplete Morphological Differentiation
At 14 weeks of gestational age, the ECM of fetal valves was predominantly composed of glycosaminoglycans, as indi-cated by the strong blue-green staining with Movat pentachrome ( Figure 1 ). The overall valve architectural structure was homogeneous and lacked distinguishable layers. By 20 weeks, fetal valves had a bilaminar structure with sparse, loose, and unorganized collagen. A trilaminar structure containing elastin in the ventricularis and increased collagen in the fibrosa became apparent by 36 weeks of gestation but remained incomplete versus the normal adult valve structure 20 ( Figure 1 ).
Fetal Valves Have High Cell Density and Proliferation Index
We found a progressive decrease in VIC density from the second and third trimesters to children's and adult valves (3032Ϯ190, 2629Ϯ214, 1410Ϯ100, and 351Ϯ58 cells per mm 2 , respectively; PϽ0.001 versus adults; Figure 2A ). Nuclei that stained positively for Ki-67, an index of cell proliferation, were distributed diffusely throughout the cusp at 14 to 19 weeks' gestation, whereas stained cells at 20 to 39 weeks of gestation and in children's valves appeared predominantly near the arterial surface ( Figure 2B ). Fetal valves at 14 to 19 weeks' gestation had higher VIC proliferation indices (26.4Ϯ1.3%, PϽ0.001 versus other groups), with an approximate 80% reduction in the third trimester (6.3Ϯ0.7%) and in children (4.2Ϯ0.5%) and a Ͼ90% reduction in adult valves (1.7Ϯ0.6%; Figure 2C ). Apoptosis continued at a low rate throughout life (0.5Ϯ0.1%, 3.3Ϯ0.3%, 1.1Ϯ0.1%, and 0.5Ϯ0.1%, respectively; PϽ0.001 for late fetal valves versus other groups). Of note, fetal valves at 20 to 39 weeks of gestation contained more VICs that were undergoing apoptosis, predominantly located near the arterial surface ( Figure  2C ). The ratio of proliferation to apoptosis was high in fetal valves at 14 to 19 weeks (52.8; PϽ0.05) but was considerably lower in late gestation and in children and adults (1.9, 3.8, and 3.4, respectively).
Fetal Valves Contain Activated Cells That Overexpress Proteolytic Enzymes
In fetal valves at 14 to 19 weeks of gestation, VICs expressed the ␣-SMA-positive phenotype, attributed to myofibroblasts, distributed predominantly in a subendocardial location below the outflow surface and throughout the deeper portion of the cusp. In contrast, ␣-SMA-positive cells in adult valves were located predominantly (and exclusively) in regions adjacent to the endothelium ( Figure 3A) . We found larger myofibroblast-like VIC populations at 14 to 19 weeks than at 20 to 39 weeks' gestation or in neonatal, child, or adult valves (28.3Ϯ1.6%, 17.4Ϯ1.3%, 20.5Ϯ2.2%, 6.2Ϯ1.7%, and 2.5Ϯ0.4%, respectively; PϽ0.001 versus fetal; Figure 3B ). VICs characterized as activated/immature myofibroblasts expressed high levels of embryonic myosin heavy chain/ SMemb and proteolytic enzymes (MMP-1, MMP-13), distributed in a homogeneous fashion throughout the cusp of fetal but not adult valves ( Figure 3A ; MMP-13 not shown). Fetal VICs at 14 to 19 weeks and 20 to 39 weeks and A, Progressive decrease in VIC density throughout life. *Significant differences in cell density between groups. B, Nuclei staining positively for Ki-67 (MIB-1) were distributed diffusely through the cusp at 14 to 19 weeks of gestation, whereas Ki-67 and TUNEL-positive cells at 20 to 39 weeks appeared predominantly near the arterial surface. Note that VICs in adult valves showed undetectable levels of proliferating and apoptotic cells. Barϭ50 m. Magnification ϫ400. C, Fetal valves at 14 to 19 weeks of gestation had higher VIC proliferation indices, with Ͼ90% reduction in adult valves. *Significant differences in cell proliferation between groups. Apoptosis continued at a low rate throughout life. #Significant differences in cell death between groups. y.o. indicates years old. Figure 3B ).
At birth, after separation of the single fetal circulation into isolated pulmonary and systemic circulations, pulmonary arterial pressure decreases and aortic pressure increases. 21 These hemodynamic changes were associated with decreased VIC activation in late neonatal (1 to 30 days of survival) pulmonary valves (6.3Ϯ0.8%; nϭ5), whereas aortic valve VICs remained activated (20.5Ϯ2.2%, nϭ5; PϽ0.05; Figure  4 ). Nevertheless, this change did not occur immediately, because the numbers of activated VICs in early neonatal valves with minutes to hours of survival were identical in both pulmonary (20.5%; nϭ5) and aortic valves (20.5%; nϭ5). Activated VICs continued to decrease after adaptation, because valves from individuals aged 2 to 16 years had similar numbers of activated VICs in pulmonary (6%; nϭ10) and aortic (6%; nϭ10) valves (Figure 4 Figure 5A and 5B). 
Collagen Content Plateaus In Utero, Whereas Elastin Content and Collagen Orientation Progressively Increase With Valve Maturity
Total collagen content, determined by picrosirius red-positive area, increased between the second (45.3Ϯ5.8%) and third (74.2Ϯ3.4%; PϽ0.001) trimesters but did not increase thereafter ( Figure 6A ). The progression from second to third trimesters was also associated with fiber color changes; the proportion of thin/green fibers decreased from 72.3Ϯ6.3% to 23.6Ϯ3.1% (PϽ0.001), whereas the proportion of thick/ orange fibers increased from 5.2Ϯ1.6% to 29.5Ϯ7.0% (Figure 6A; PϽ0.05) . We found no color difference between late fetal and children's valves; however, the progression to adult valves saw further reductions in green fibers (7.1Ϯ1.7%) and increases in orange fibers (46.8Ϯ6.7%; PϽ0.05 versus child), even though there was no increase in total collagen. Although we found no intergroup difference in the proportion of red collagen pixels (range 0.9% to 1.8%; PϭNS), our results indicate changes in collagen fiber thickness during valve maturation ( Figure 6B) .
Although there was a small postnatal reduction in angular deviation, this change was not significant ( Figure 6C ). In contrast, angular deviation in adult valves decreased (PϽ0.01 versus other groups), which indicates a significant increase in fiber alignment, illustrated in the representative orientation distributions. These distributions represent the relative orien- Figure 6 . Quantitative assessment of collagen content and orientation in cardiac valves from fetus to adult. A, Total collagen content increased between early and late fetal (PϽ0.001) stages but did not increase in children's and adult valves. The progression from early to late fetal was also associated with collagen fiber thickness changes: the proportion of thin/green fibers decreased (PϽ0.001), whereas the proportion of thick/orange fibers increased (PϽ0.05). Note no difference between late fetal and children's valves; however, the progression to adult valves saw further reductions in thin/ green fibers and increases in thick/orange fibers (PϽ0.05 vs children), even though there was no increase in total collagen. B, Changes in collagen fiber thickness during valve maturation demonstrated by hue analysis. Color threshold images show the spatial distribution of green pixels, an indication of thin fibers, and orange pixels, an indication of thick, more mature fibers. Fetal valves contained more green collagen, whereas adult valves had more orange collagen. C, Angular deviation in adult valves significantly decreased (*PϽ0.01 vs other groups), which indicates increased collagen fiber alignment. D, Representative collagen fiber orientation distributions in early fetal and adult valves. *, #, § indicate significant differences.
tation of fibers within the region analyzed, rather than orientation relative to a specific direction ( Figure 6D ).
Elastin was measured as a black-positive area with Movat pentachrome stain and expressed as a percent of the area of the ventricularis layer. Elastin content was negligible at 14 weeks' gestation (0.7Ϯ0.1%). The first discernable fibers appeared on the ventricular aspect in the base of the cusps at the end of the third trimester (3.8Ϯ0.5%). Total elastin content increased in children's valves (8.2Ϯ2.2%) and was higher yet in adult semilunar valves (25.1Ϯ3.9%; PϽ0.05; Figure 7A ). Adult aortic valves had more elastin (32.3Ϯ2.7%) than pulmonary valves (17.9Ϯ2.7%, PϽ0.001; Figure 7B ).
Discussion
This study focused on the evolution in cell phenotypes and ECM remodeling with valve maturation. We demonstrated that fetal valves possess a dynamic/adaptive structure and contain cells with an activated/immature phenotype. During postnatal life, activated cells gradually become quiescent, whereas collagen matures through increased fiber thickness and alignment, which suggests a progressive, environmentally mediated adaptation.
Semilunar Valve Architecture Changes Throughout Development and Into the Postnatal Period
The fetal circulation differs from that of adults owing to shunts that equalize left and right ventricular pressures: the foramen ovale between the right and left atrium and ductus arteriosus between pulmonary artery and aorta. Thus, fetal semilunar valves and the aorta and pulmonary trunk are subjected to equal pressures, which progressively increase during gestation. 21 The present study revealed that fetal, second-trimester semilunar (aortic and pulmonary) valves lacked distinguishable layers, were composed primarily of proteoglycans, had no detectable elastin, had small amounts of disorganized collagen, and were histologically identical (likely because of a similar physiological environment during development 22 ). Valvular ECM elements accommodate repetitive shape and dimension changes throughout the cardiac cycle and must adapt to different mechanical stresses throughout life. Therefore, it is not surprising that pressure increases during gestation increased collagen and elastic fiber content and increased collagen fiber alignment (Figures 1 and 6) . Nevertheless, fetal valve structure differed, even late in gestation, from that of adult valves, which have a trilayered architecture with a highly specialized and functionally adapted ECM (Figure 1 ). These observations suggest that valvular cusp morphogenesis continues throughout development and into the postnatal period. After birth, the foramen ovale closes and the ductus arteriosus occludes, which results in separation of the pulmonary and systemic circulations. Lower pressure in the pulmonary circulation is eventually reflected in adult pulmonary valve cusps that are more delicate than the aortic, whereas higher pressure in the systemic circulation produces thicker aortic cusps, 7 with dense collagen fibers arranged parallel to the free edges of the cusp, predominantly on the arterial aspect, and more elastic fibers on the ventricular side ( Figure 7B ).
Turnover of Valve Interstitial Cells Is High During Fetal Development and Continues at a Low Rate Postnatally
During valve morphogenesis and development, cells of the cardiovascular system differentiate and proliferate and can migrate over large distances while they produce, degrade, and remodel ECM. Cells originating in the neutral crest, for example, migrate to the cardiovascular system and are critical to the formation of several structures, including the semilunar valves. 23 During valve formation, cardiac cushions appear as localized expansions of ECM, known as cardiac jelly. Endothelial cells then invade the cushions, transform into mesenchymal cells, 1 and eventually form the inflow (mitral and tricuspid) and outflow (aortic and pulmonary) valves, a process aided in part by cell proliferation 24 and apoptosis. 25 The present study demonstrates that fetal valves have much higher cellular densities than adult valves, associated with an increased cell proliferation-to-apoptosis ratio. VIC density was highest in the second trimester, Ϸ10-fold higher than in adult valves, and decreased progressively throughout gestation and postnatally. Fetal VIC proliferation indices were likewise greater than those of adult valves. Lincoln and colleagues 24 demonstrated decreased proliferation indices in chicken embryo valve primordia (calculated as the number of bromodeoxyuridine-positive nuclei/total nuclei), which supports the present finding that valve maturation is accompanied by decreased proliferation. We speculate that the higher rates of apoptosis in the late gestational period may reinforce the decreased cell proliferation at that interval to more rapidly and effectively arrest cuspal growth. The present study also demonstrates that valvular cell turnover is high during fetal development and continues at a low rate postnatally ( Figure  2C ) and that the total number of cells decreases substantially throughout life (Figure 2A ), a fact that might account for slower or incomplete valve remodeling in older adults and predisposition to clinically important valve degeneration.
Activated Myofibroblasts Mediate Collagen Metabolism During Valve Maturation
We also demonstrated VIC plasticity throughout gestational valve maturation, in contrast to the resting VIC population of normal adult valves and their predominantly fibroblast-like phenotype. 8 We observed that a large number of fetal VICs exhibited an ␣-SMA-positive phenotype attributed to myofibroblast-like cells (Figure 3 ). Diseased valves also contain numerous myofibroblast-like VICs that express ␣-SMA, which suggests a role for myofibroblasts in valvular connective tissue remodeling. 7, 8 Moreover, we found that fetal VICs had abundant SMemb (nonmuscle myosin produced by embryonic or activated cells), MMP-1/collagenase-1, and MMP-13/collagenase-3, which indicates an activated/immature phenotype compatible with matrix remodeling. Despite the well-established role played by MMPs in pathological processes, including myxomatous mitral valve degeneration 6 and atherosclerosis, 10, 15 their role in remodeling normal valves and in fetal valve development remains unknown. We found more MMP-1 and MMP-13 in fetal valves, particularly late in gestation, than in adult valves, whereas collagen content increased during valve maturation. This inverse relationship suggests a critical role for MMPfamily collagenases in collagen metabolism in cardiac valve development. A significant increase in collagen fiber thickness and alignment occurred between childhood and adulthood, whereas collagenase expression was negligible; however, whether this is due to prolonged exposure to mechanical forces or reflects completion of cell-and enzyme-associated remodeling is unknown.
Activated Myofibroblasts Undergo Phenotypic Modulation at Birth and Become a Quiescent Fibroblast-Like Cell Type During Adulthood
Previous studies reported that altered mechanical forces 8, 26 and injury 27 are associated with phenotypic changes of valvular cells. Of particular interest in the present study was the way in which valves responded to abrupt change in blood pressures and other hemodynamic conditions at birth after separation of the single fetal circulation into isolated pulmonary and systemic circulations. Therefore, we also focused on comparison between fetal and neonatal pulmonary and aortic valves. Blood pressure in the fetal aorta and pulmonary artery is approximately 50/15 mm Hg. At birth, pulmonary pressure falls to 30/15 mm Hg; however, arterial pressure increases to 70/40 mm Hg. We found that the change from fetal to neonatal circulation correlated with reduced VIC activation (Ϸ6%) in neonatal pulmonary valves versus aortic valves (Ϸ21%; Figure 4 ). 28 Whether these changes might also be stimulated by changes in local blood oxygen content is unknown. In children's valves, the numbers of activated VIC were similar in both pulmonary and aortic locations, which suggests tissue adaptation to pulmonary and systemic circulations.
Endothelial Cells Express an Activated Phenotype Throughout Fetal Development, a Phenotype Distinct From Adult Valves
Observations suggest that valvular endothelium is unique compared with other types of endothelial cells (particularly aortic and cardiac microvascular endothelium). 29 The endothelium regulates vascular tone, inflammation, thrombosis, and vascular remodeling. 30 Structurally intact endothelial cells can respond to pathophysiological stimuli by adjusting their usual functions and by expressing newly acquired properties, a process termed "endothelial activation." Activated endothelial cells produce a variety of biologically active products, including cytokines, growth factors, proteolytic enzymes, and adhesion molecules. Normal endothelial function is characterized by a balance of these factors and the cells' ability to respond appropriately to stimuli. The present study demonstrated physiological activation of endothelial cells that consistently expressed high levels of SMemb, MMP-1, MMP-13, ICAM-1, and VCAM-1 in fetal and children's valves. In contrast, adult valves had negligible expression of these molecules ( Figure 5 ).
Clinical and experimental evidence suggests that valve leaflet endothelium is protected from inflammatory and immune-mediated injury by reduced expression of adhesion molecules, including VCAM-1, which is abundant in cardiac microvascular endothelium of rejected orthotopic heart transplants and in pig hearts after transplantation into baboons. 31 The present study demonstrates consistent ICAM-1 and VCAM-1 expression by human fetal VECs during mid to late gestation. Furthermore, ICAM-1 and VCAM-1 expression has been found in surgically removed diseased valves 32, 33 and in vitro, 34 which suggests that other factors, such as hemodynamic forces, may contribute to protection from inflammatory cell infiltration. Nevertheless, understanding endothelial adhesion molecule function in vivo in the presence of complex blood flow patterns requires further investigation.
Study Implications
The present study provides a natural history of cell and matrix changes in valve development, maturation, and adaptation (summarized in Figure 8 ) and extends the paradigm, previously suggested by us, that cardiac valvular tissue can adapt to environmental conditions, particularly mechanical loading. 8 Specifically, under equilibrium conditions, VICs are quiescent and ECM is well adapted. We hypothesize that when stimulated by mechanical loading, VICs become activated and mediate connective tissue remodeling to restore a normal stress profile in the tissue. When equilibrium is restored, cells return to quiescence. The present study demonstrates that fetal VIC activation occurs throughout development, analogous to the valve changes that occur in pathological conditions and after surgical substitution. 6, 7 Thus, analogous molecular mechanisms likely direct both physiological and pathological interstitial cell activation. Furthermore, our characterization of human semilunar valve VIC and VEC phenotypes and dynamic ECM changes from fetus to adult also indicates potential markers of cell activation/ maturation and matrix alterations (eg, MMP-1, MMP-13, embryonic myosin, VCAM-1, and ICAM-1). These molecules are overexpressed during fetal valve development, several valvular diseases, and surgical transplantation and in tissue-engineered valves [7] [8] [9] and therefore may represent targets for molecular imaging to noninvasively monitor biological processes during healing and remodeling. Moreover, the progressive age-associated decrease in cell number and active capacity for remodeling may be an important clue in understanding senile valve degeneration.
Conclusions
We demonstrated that fetal valves possess a dynamic/adaptive structure and contain activated/immature cells. Moreover, the valvular cells that were activated in utero undergo phenotypic changes at birth and gradually become quiescent, whereas collagen matures through increased fiber thickness and alignment. This suggests a progressive adaptation to the prevailing hemodynamic environment. Knowledge of cell and matrix changes during fetal valve maturation may aid in the development of therapy for valve disease and assist in the design and evaluation of tissue-engineered valves. [35] [36] [37] 
